Journal Articles Candellone A, Cerquetella M, Girolami F, Badino P, Odore R. Acute Diarrhea in Dogs: Current Management and Potential Role of Dietary Polyphenols Supplementation. Antioxidants (Basel). 2020 Aug 9;9(8):725. doi: 10.3390/antiox9080725. PMID: 32784917; PMCID: PMC7465157.
Shmalberg J, Montalbano C, Morelli G, Buckley GJ. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front Vet Sci. 2019 Jun 4;6:163. doi: 10.3389/fvets.2019.00163. PMID: 31275948; PMCID: PMC6593266.
Pignataro G, Di Prinzio R, Crisi PE, Belà B, Fusaro I, Trevisan C, De Acetis L, Gramenzi A. Comparison of the Therapeutic Effect of Treatment with Antibiotics or Nutraceuticals on Clinical Activity and the Fecal Microbiome of Dogs with Acute Diarrhea. Animals (Basel). 2021 May 21;11(6):1484. doi: 10.3390/ani11061484. PMID: 34063855; PMCID: PMC8223982.
Chaitman J, Ziese AL, Pilla R, Minamoto Y, Blake AB, Guard BC, Isaiah A, Lidbury JA, Steiner JM, Unterer S, Suchodolski JS. Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole. Front Vet Sci. 2020 Apr 16;7:192. doi: 10.3389/fvets.2020.00192. PMID: 32363202; PMCID: PMC7182012.
Langlois DK, Koenigshof AM, Mani R. Metronidazole treatment of acute diarrhea in dogs: A randomized double blinded placebo-controlled clinical trial. J Vet Intern Med. 2020 Jan;34(1):98-104. doi: 10.1111/jvim.15664. Epub 2019 Nov 19. PMID: 31742807; PMCID: PMC6979100.
Tong, J. O. P. (2019). In canine acute diarrhoea with no identifiable cause, does daily oral probiotic improve the clinical outcomes?. Veterinary Evidence, 4(4). https://doi.org/10.18849/ve.v4i4.252
Moreno AA, Parker VJ, Winston JA, Rudinsky AJ. Dietary fiber aids in the management of canine and feline gastrointestinal disease. J Am Vet Med Assoc. 2022 Oct 26;260(S3):S33-S45. doi: 10.2460/javma.22.08.0351. PMID: 36288203.
Moore, E., & Gordon-Evans, W. . (2022). Should we prescribe oral metronidazole or probiotics for acute gastroenteritis in dogs?. Veterinary Evidence, 7(2). https://doi.org/10.18849/ve.v7i2.393
Holden, R. and Brennan, M. (2021), Does metronidazole increase the speed of recovery in dogs with acute diarrhoea?. Veterinary Record, 188: 33-34. https://doi.org/10.1002/vetr.44
Nixon, SL, Rose, L, Muller, AT. Efficacy of an orally administered anti-diarrheal probiotic paste (Pro-Kolin Advanced) in dogs with acute diarrhea: A randomized, placebo-controlled, double-blinded clinical study. J Vet Intern Med. 2019; 33: 1286– 1294. https://doi.org/10.1111/jvim.15481
Chaitman, Jennifer, and Frédéric Gaschen. “Fecal microbiota transplantation in dogs.” Veterinary Clinics: Small Animal Practice 51.1 (2021): 219-233.
Rudinsky, Adam J., et al. “Randomized controlled trial demonstrates nutritional management is superior to metronidazole for treatment of acute colitis in dogs.” Journal of the American Veterinary Medical Association 260.S3 (2022): S23-S32.
I have written about the emerging liquid biopsy tests a couple of times before (here and here). These are blood tests that are intended to find signs of cancer circulating in the blood. This can be used for screening, testing individuals with no clinical symptoms or reason to expect cancer is present, or for help in diagnosing a cancer that is suspected to be there for some other reason. I have focused on the OncoK9 test because that was both the first onee I came across and because the company has been publishing some useful follow-up research on the test since it was first released. The specifics will likely be different for each type of liquid biopsy test, but the general principles are much the same.
The potential benefits of these tests are earlier detection of cancer, which is sometimes helpful in providing more effective treatment. However, for some cancers in dogs and cats we don’t have effective treatments available, and there is little actual evidence showing that earlier treatment improves outcomes for most veterinary cancer patients, so the benefit of earlier detection is difficult to assess.
There are also potential risks to these tests. Telling owners their pets have cancer when they really don’t, and reassuring them no cancer is present when it actually is, or when it could develop at any time after the test, can be harmful to owners and to their pets. Additional testing, particularly invasive tests like biopsies, can also cause harm, and this is not always balanced by a benefit to the pet. The subjects of overdiagnosis and the rational use of diagnostic and screening tests are ones I talk about often, though I’m not convinced I have yet had an impact on how vets make use of the tests we have available.
PetDx, the company making the OncoK9 liquid biopsy test, recently published a study looking back at test results and records from hospitals using their product and providing some information about how the test performs.
The study evaluated the results of 1500 tests submitted by veterinary clinics and attempted to determine the actual diagnosis and outcome for the patients to evaluate the accuracy of the test results. The results are broadly similar to those of the company’s previous study (discussed here), which is encouraging. It is worth noting, however, that both studies were funded and conducted by company employees, so the potential for unconscious bias to influence the methods and results is worth keeping in mind. The similarities may mean the test performs consistently in different populations of dogs, or it could be a reflection of the similar methods and biases in the design and execution of the studies.
About 64% of the tests conducted were run in patients without suspicion of cancer (screening), and 26% were submitted to aid in the diagnosis of a suspected cancer. Personally, I believe screening is the riskier of the two uses for this test, so it is disappointing that the company has been so successful at marketing this as a test to be used “just in case” there is cancer in health older pets. Those are the patients for whom the risks of overdiagnosis and overtreatment are likely the highest. Of course, they are also more likely than younger dogs to have cancer, so some will benefit from this testing, but most will not have the disease, and the balance of risks and clinical benefits is far from clear.
The test performed about the same as in the previous study. Overall, the Positive Predictive Value (PPV- the proportion of dogs with a positive test that actually had cancer) was about 89% and the Negative Predictive Value (NPV- the proportion of dogs with a negative test that did not have cancer) was about 88%. These are decent numbers, but they do suggest that about 10% of dogs with a positive test don’t have cancer, which is still a fair number of owners frightened and dogs potentially subjected to unnecessary follow-up testing, or even potentially cancer treatment or euthanasia, to no purpose. Likewise, a bit over 10% of dogs with a negative test, might actually have cancer, and this result could delay needed testing and treatment.
In the most vulnerable group, healthy dogs being screened for cancer, only 4.5% had a positive result. The proportion of these who actually had cancer (the PPV) was 75%, compared with 98% of those tested to help confirm suspected cancer. This reinforces that we must be pretty cautious about how we react to a positive screening test when ¼ of those will not actually end up having cancer. As expected, the reverse is also true: the NPV of dogs screened was 94% (most who were tested didn’t have cancer and most testing negative didn’t have cancer) compared to an NPV of 67% for the dogs tested because of other signs of possible cancer (a fair number of these actually had cancer, and so negative tests were less consistently correct).
A relatively small number of patients in this study had failed tests or uncertain results, and most of these got a clear yes or no answer on repeating the test. This is still a source of anxiety, frustration, and delay for those patients and their owners, but no test is ever perfect.
All-in-all, I think these types of tests are reasonable to use for trying to help decide if a dog with findings suggestive of cancer which can’t be confirmed or refuted in a more definitive way. I have run the test in one dog with a heart mass that could either have been an aggressive or a slow-growing tumor (with very different paths for the owner to choose from) and which, for obvious reasons, we couldn’t biopsy. In that case, unfortunately, the test did not find evidence of cancer, but the patient declined rapidly, which suggested something more aggressive, though no definitive diagnosis could be made.
I have become a bit more positive in my view of these tests since I first wrote about them because the studies coming out suggests they are reasonably accurate. However, there is still no clear evidence that using these tests, at least in dogs with no other reason to suspect cancer, leads to longer life or delayed illness, and that is ultimately the point of screening. I hope this company continues to evaluate the real-world impact of the use of its tests, that other makers of such tests also do so, and ultimately that independent studies unconnected with the manufacturers of these products can provide data showing how they perform and what benefits, if any, they provide. New diagnostic and screening tests can be very valuable, but like anything in medicine they have risks as well as benefits, and it can take a bit of time and effort to determine what these are and when we should, or should not use a particular test.
Stookey GK. Soft Rawhide Reduces Calculus Formation in Dogs. Journal of Veterinary Dentistry. 2009;26(2):82-85. doi:10.1177/089875640902600202
Hennet P. Effectiveness of an Enzymatic Rawhide Dental Chew to Reduce Plaque in Beagle Dogs. Journal of Veterinary Dentistry. 2001;18(2):61-64. doi:10.1177/089875640101800201
Hooda S. In vitro digestibility of expanded pork skin and rawhide chews, and digestion and metabolic characteristics of expanded pork skin chews in healthy adult dogs, Journal of Animal Science, Volume 90, Issue 12, December 2012, Pages 4355–4361, https://doi.org/10.2527/jas.2012-5333
Christine Arhant, Rebecca Winkelmann, and Josef Troxler. “Chewing Behaviour In Dogs – A Survey-based Exploratory Study.” Applied animal behaviour science, v. 241 ,. pp. 105372. doi: 10.1016/j.applanim.2021.105372
Bellows J, Berg ML, Dennis S, Harvey R, Lobprise HB, Snyder CJ, Stone AES, Van de Wetering AG. 2019 AAHA Dental Care Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2019 Mar/Apr;55(2):49-69. doi: 10.5326/JAAHA-MS-6933.
Harvey CE, Shofer FS, Laster L. Correlation of Diet, Other Chewing Activities and Periodontal Disease in North American Client-Owned Dogs. Journal of Veterinary Dentistry. 1996;13(3):101-105. doi:10.1177/089875649601300304
If you are interested in canine and feline aging, I have a new continuing education course available on the Veterinary Information Network (VIN). Two hours of a pre-recorded self-study course and two hours of live, interactive sessions focusing on:
Session 1 (self-study) Introduces key geroscience concepts and core physical, function, behavioral, and metabolic changes in aging dogs and cats
Session 2 (self-study) Covers the concept of frailty, reviews significant clinical disorders in geriatric dogs and cats, and begins looking at what we can do about aging
Session 3 (August 9, 2023 5pm PDT) Introduces specific clinical assessment tools and case study examples for the independent practice exercise
Session 4 (August 30, 2023 5pm PDT) A review of the case examples and course wrap-up
This is the proceeding summary and the slide deck from my presentation on Nutrition and Aging at the 2023 ACVIM Forum in Philadelphia.
Effect of Nutritional Interventions on Aging
INTRODUCTION While the clinical phenotype of aging is readily identifiable, a precise definition of this ubiquitous phenomenon is challenging. A useful pragmatic definition is the accumulation of changes over time that increase an individual’s susceptibility to disability, disease, and death. The passage of time is a key factor, yet it is not the primary driver of aging. Factors such as genetics, environmental exposures, and nutrition also play critical roles.
The cellular and molecular changes characteristic of mammalian aging are often grouped into categories known as hallmarks of aging (Figure 1).1 Though not exhaustive, this scheme provides useful starting points for investigations into the mechanisms of aging and for evaluation of interventions to influence this process and mitigate the negative health outcomes resulting from it.
Figure 1. Hallmarks of aging.1
The scientific understanding of these hallmarks, and how they can be manipulated, has reached a point at which aging can reasonably be viewed as a modifiable risk factor for disability, disease, and death. The length of time an individual lives (lifespan) and the proportion of that life free of significant age-associated disability or disease (healthspan) can be extended by targeting the underlying mechanisms of aging.
Interventions so far demonstrated to increase lifespan and healthspan in animal models include modifications of activity level and environmental conditions, pharmaceuticals, and diet.
There are various ways in which diet can potentially impact health and longevity-
Dietary interventions to prevent and treat age-associated disease (e.g. dietary therapy of chronic kidney disease in cats)2
Optimization of diet to match changing nutritional requirements throughout the lifecycle (e.g. differences in the protein content of diets formulated for puppies and for geriatric dogs)3
Optimization of diet for individual health (e.g. potential applications of nutrigenomics and metabolomics)4
Extension of lifespan and delay or prevention of age-associated disease through dietary interventions targeting specific hallmarks of aging
The last approach has been the focus of extensive research since at least the early twentieth century, when it was first shown that reduced food intake extend lifespan in rats.5 The field has progressed from rather crude, trial-and-error methods to the evaluation of specific cellular and molecular mechanisms that can be stimulated and inhibited to achieve substantial changes in median and maximum lifespan and in health. The primary, though by no means only, hallmark of aging targeted by dietary interventions is dysregulated nutrient sensing.6
NUTRIENT SENSING AND AGING Nutrient sensing involves a complex network that detects the availability of nutrients and energy and regulates cellular growth and metabolism, apoptosis and autophagy, protein synthesis, and other processes depending on the available nutritional resources. The functioning of these mechanisms changes in a consistent pattern with aging, though the rate of this change differs between species and even between individuals. These changes are a key element in the degenerative process of aging and the increasing susceptibility to disease and death.
Critical pathways maintaining an appropriate balance between the energy and nutrients taken in and the function and maintenance of an organism are highly conserved across organisms as evolutionarily distant as flatworms, fruit flies, rodents, dogs and cats, and humans. An example is the target-of-rapamycin (TOR) protein kinase, homologues of which regulates cell proliferation, protein synthesis, and many other anabolic processes in yeast just as in mammals.5,6
A recurring motif in aging biology is that nutritional stress, such as reduced availability of calories or specific nutrients, can suppress some nutrient sensing pathways and activate others, with a net effect of inhibiting age-related disease and extending lifespan. These pathways are complex and interact extensively with each other and with many other physiologic processes, so simple generalizations are inherently problematic. However, sufficiently consistent patterns have emerged in a variety of organisms to allow a broad but useful characterization of some key elements and their influence on lifespan and healthspan when activated or suppressed by dietary interventions. Table 1 provides a brief list of some key regulators in these pathways and their typical impact on lifespan when activated or suppressed.
Table 1. Key regulators of nutrient sensing pathways.
Regulator
Activities
Effects on Lifespan
“Bad Guys”
mTOR (mechanistic target of rapamycin)
Increases cell growth, cell division, protein synthesisPromotes anabolism
Activity increases with ageHigh activity promotes aging and age-related diseaseSuppression increases lifespan
High activity reduces lifespanSuppression increases lifespan
“Good Guys”
AMPK (AMP-activated protein kinase)
Promotes catabolism and suppresses anabolismSuppresses mTORStimulates FOXO and SIRT
Activity declines with ageHigh activity increases lifespan
FOXO (forkhead box O transcription factors)
Coordinates nutritional stress responseRegulates energy metabolism, cellular proliferation and apoptosis, redox balance, autophagyInhibits mTOR
High activity increases lifespan
SIRT (NAD+-dependent sirtuin deacetylases)
Regulates energy metabolism and balance between anabolism and catabolismInhibits mTORStimulates FOXO
High activity increases lifespan
DIETARY INTERVENTIONS TO INCREASE LIFESPAN
Caloric Restriction (CR) Defined as significant reduction in calorie intake (typically 20-50%) without malnutrition or change in macronutrient ratios, CR has been consistently shown to increase lifespan and reduce the burden of age-related disease in multiple species, including rats and mice, primates, and dogs.5,7,8 The effects of this intervention are broad, but suppression of mTOR and activation of AMPK and SIRT are considered central mechanisms in this approach.6,9 Pharmacologic CR mimetics targeting these mechanisms have also extended lifespan and healthspan in some studies.10
CR is the most consistently effective dietary intervention for extending lifespan and healthspan. However, there are limitations to this approach. Some studies involved concurrent protein restriction or control animals with obesity and metabolic dysfunction, which complicates determination of the true effect size of pure CR. Genetic background also influences the impact of CR, and some strains of mice show no benefit or even reduction in lifespan.5 Such an extreme intervention is also too impractical and potentially dangerous for routine use in humans or companion animals.
Protein and Selective Amino Acid Restriction Rodent studies have demonstrated extension of lifespan with general protein restriction and with selective restriction of sulfur-containing amino acids (e.g. methionine, cysteine) and branched-chain amino acids (BCAA; e.g. leucine, valine). Some of these have also involved CR, but benefits have been seen with isocaloric protein and amino acid restriction, though the effect size is considerably smaller than that of CR. Inhibition of GH/IGF-1 and mTOR appear to be the main mechanisms for this effect.5,11
Timing of Feeding Manipulations of the timing of feeding, including fasting regimes, time-limited feeding, or cyclic intermittent CR have all been shown to extend lifespan. Most of these regimes amount to a form of CR, but they may be more sustainable in real-world use. A few studies of isocaloric manipulations of the timing of feeding have also shown positive effects on glucose, insulin, and IGF-1 and the induction of short-term ketosis, all of which might have beneficial effects on lifespan and healthspan, though this has not be conclusively demonstrated.5
Ketogenic Diets (KD) Carbohydrates-restricted diets which induce ketogenesis, as well as direct administration of some ketone bodies, have been shown in a few studies to increase lifespan and healthspan in mice and invertebrate models of aging. Such diets may mimic the effect of CR in shifting metabolism away from glycolysis and towards fatty-acid oxidation. Some KD formulations may also be protein-restricted and inhibit mTOR activity. The evidence supporting the effect of KD on longevity, however, is currently quite limited.
DIETARY INTERVENTIONS FOR LONGEVTIY IN COMPANION ANIMALS Extension of lifespan and healthspan by CR has been demonstrated in dogs, and there is some limited evidence that other dietary manipulations might increase longevity in cats.7,12 However, the potential impact of CR, protein restriction, and ketogenic diets on aging in companion animals is largely unknown, and most strategies are based on speculation and extrapolation from research in rodents or other laboratory animals.
Unfortunately, strong claims for lifespan extension have been made for various dietary interventions, including raw diets, “fresh food,” and ketogenic diets. These claims are not based on robust, target-species research and present a misleading picture of the state of the science in this area. The belief that an optimal diet for longevity is known and can be formulated for dogs and cats, or even for individual animals, is unjustified and places an unfair and unsupportable burden on pet owners to choose the “right” food.
Future studies investigating the hallmarks of aging and their response to dietary manipulations as well as clinical studies directly assessing the impact of novel feeding strategies on lifespan and healthspan are needed before clinical recommendations regarding diet and longevity can be made with confidence. Until that evidence is available, it is most appropriate to continue offering current, evidence-based dietary recommendations.
REFERENCES
1. López-Otín C, et al; Hallmarks of aging: An expanding universe. Cell 2023;186(2):243.
2. Ross SJ, et al; Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 2006;229(6):949.
3. Laflamme DP; Nutrition for aging cats and dogs and the importance of body condition. Vet Clin North Am Small Anim Pract 2005;35(3):713.
4. Ordovas JM, et al; Personalized nutrition and healthy aging. Nutr Rev 2020;78(12 Suppl 2):58.
5. Lee MB, et al; Antiaging diets: Separating fact from fiction. Science 2021;374(6570).
6. Pignatti C, et al; Nutrients and Pathways that Regulate Health Span and Life Span. Geriatr 2020;5(4):1.
7. Lawler DF, et al; Diet restriction and ageing in the dog: major observations over two decades. Br J Nutr2008;99(4):793.
8. Pifferi F, et al; Caloric restriction, longevity and aging: Recent contributions from human and non-human primate studies. Prog Neuropsychopharmacol Biol Psychiatry. 2019;95.
9. Green CL, et al; Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2022;23(1):56.
10. Madeo F, et al; Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential. Cell Metab. 2019;29(3):592.
11. Brandhorst S, et al; Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity. Adv Nutr. 2019;10(Suppl 4):S340.
12. Cupp C, et al; Effect of Nutritional Interventions on Longevity of Senior Cats. Int Jounrla Appl Res Vet Med. 2007;5(3):133.